Laura Williams
Family · Douglas, GANPI 1710432109
Payments from drug & device makers
Across 159 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$715
- Novo Nordisk$326
- Electromed, Inc.$245
- Mylan Specialty L.p.$238
- AstraZeneca$163
- Amgen$157
- plus $943 from 24 others
What the payments were for
- Food & beverage$2,787100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 38 | $715 |
| Novo Nordisk | 21 | $326 |
| Electromed, Inc. | 11 | $245 |
| Mylan Specialty L.p. | 16 | $238 |
| AstraZeneca | 10 | $163 |
| Amgen | 10 | $157 |
| AbbVie | 5 | $92 |
| Lilly USA, LLC | 6 | $89 |
| Sumitomo Pharma America, Inc. | 3 | $84 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $77 |
| Daiichi Sankyo Inc. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| E.r. Squibb & Sons, L.L.C. | 3 | $53 |
| Shield Therapeutics Inc | 3 | $45 |
| Pfizer | 3 | $44 |
| Exact Sciences | 3 | $42 |
| Boston Scientific | 2 | $39 |
| Dexcom, Inc. | 1 | $36 |
| Bayer | 2 | $35 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Novartis | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Biogen | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Aurinia Pharma U.S., Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Millicent US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SMARTVEST$118
How this compares
$2,787 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 120 | $147,900 |
| OzempicSemaglutide | 67 | $101,799 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 82 | $69,103 |
| LinzessLinaclotide | 80 | $61,338 |
| FarxigaDapagliflozin Propanediol | 70 | $55,585 |
| EliquisApixaban | 74 | $54,419 |
| VraylarCariprazine Hcl | 33 | $53,775 |
| RybelsusSemaglutide | 31 | $36,934 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 47 | $35,778 |
| Nurtec OdtRimegepant Sulfate | 20 | $32,890 |
| EntrestoSacubitril/Valsartan | 20 | $24,451 |
| TrulicityDulaglutide | 20 | $22,825 |
| JardianceEmpagliflozin | 25 | $21,347 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $21,299 |
| Repatha SureclickEvolocumab | 20 | $17,650 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $89 | $170,726140 claims |
| Novo NordiskOzempic, Rybelsus | $326 | $138,73298 claims |
| AbbVieLinzess, Vraylar | $92 | $115,113113 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $163 | $91,362117 claims |
| PfizerEliquis, Nurtec Odt | $44 | $87,30994 claims |
| GSKTrelegy Ellipta | $715 | $69,10382 claims |
| NovartisEntresto | $21 | $24,45120 claims |
| Astellas Pharma US IncMyrbetriq | $18 | $15,57119 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $77 | $11,44122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,258 family providers in Georgia.
Other family in Douglas
- Farah SmithDouglas$15K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.